Phospho-CCNB2(S10) Antibody
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| DB, E |
---|---|
Primary Accession | O95067 |
Other Accession | Q4R7A8, NP_004692.1 |
Reactivity | Human |
Predicted | Monkey |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 45282 Da |
Gene ID | 9133 |
---|---|
Other Names | G2/mitotic-specific cyclin-B2, CCNB2 |
Target/Specificity | This CCNB2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S10 of human CCNB2. |
Dilution | DB~~1:500 E~~Use at an assay dependent concentration. |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | Phospho-CCNB2(S10) Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | CCNB2 |
---|---|
Function | Essential for the control of the cell cycle at the G2/M (mitosis) transition. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Cyclin B2 is a member of the cyclin family, specifically the B-type cyclins. The B-type cyclins, B1 and B2, associate with p34cdc2 and are essential components of the cell cycle regulatory machinery. B1 and B2 differ in their subcellular localization. Cyclin B1 co-localizes with microtubules, whereas cyclin B2 is primarily associated with the Golgi region. Cyclin B2 also binds to transforming growth factor beta RII and thus cyclin B2/cdc2 may play a key role in transforming growth factor beta-mediated cell cycle control.
REFERENCES
Cunningham, J.M., et al. Br. J. Cancer 101(8):1461-1468(2009)
Haraguchi, T., et al. Fertil. Steril. 91 (4 SUPPL), 1424-1426 (2009) :
De Martino, I., et al. Cancer Res. 69(5):1844-1850(2009)
Bellanger, S., et al. Oncogene 26(51):7175-7184(2007)
Stav, D., et al. Int. J. Biol. Markers 22(2):108-113(2007)

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.